Pluvicto to treat challenging prostate cancer
Drug Name: Pluvicto Active Ingredient: lutetium (177Lu) vipivotide tetraxetan Indications: To treat prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer following other therapies Approval Date: 3/23/2022 Company: Advanced Accelerator Applications USA,…